About 140 employees are affected, about 25% of its workforce, according to Vir Biotechnology, Inc.'s latest layoff filing, on August 1, 2024. As of November 15, 2026, Vir Biotechnology, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, August 1, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Vir Biotechnology, Inc.
Free to see. No signup.
People from Vir Biotechnology, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Vir Biotechnology, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Vir Biotechnology, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Vir Biotechnology have layoffs in 2024? What its filings say
Vir Biotechnology, Inc. (CIK 1706431) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-08-01
Employees affected
Impacted employees represent approximately 25% of the Company's workforce, or approximately 140 employees.
Expected charges
As a result of these changes, the Company expects to incur restructuring charges between $11 million to $13 million, primarily related to employee severance cash expenditures.
Also on the record for Vir Biotechnology, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 10, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 4.6% of the class | 5%+ stakes | Source |
| November 6, 2026 | Stake report, Schedule 13D/A, by ARCH Venture Fund IX, L.P. | 7.3% of the class | 5%+ stakes | Source |
| October 28, 2026 | Leadership change: Suzanne Topalian appointed, Director | — | Leadership changes | Source |
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 12.4% of the class | 5%+ stakes | Source |
| October 1, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.9% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G/A, by Vanguard Portfolio Management | 6.85% of the class | 5%+ stakes | Source |
| July 24, 2026 | Leadership change: Brent Sabatini appointed, Chief Accounting Officer | — | Leadership changes | Source |
| June 10, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 28, 2026 | Leadership change: Saira Ramasastry departs, Director | — | Leadership changes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by SB Investment Advisers (UK) Limited | 6.5% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.79% of the class | 5%+ stakes | Source |
Keep reading
More on Vir Biotechnology, Inc. and the records around it.
Vir Biotechnology, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Leadership changes Jul 2026
- Who owns it
Companies that share a holder
- ARCH Venture Fund IX, L.P. also filed stake reports on 2 other companies: Lyell Immunopharma, Inc. (Nov 2026), Sana Biotechnology, Inc. (Aug 2026)
- SB Investment Advisers (UK) Limited also filed stake reports on 5 other companies: Energy Vault Holdings, Inc. (May 2026), Compass, Inc. (Feb 2026), Roivant Sciences Ltd. (Feb 2026)
- STATE STREET CORPORATION also filed stake reports on 378 other companies: 4D MOLECULAR THERAPEUTICS INC (Nov 2026), ACADIA PHARMACEUTICALS INC (Nov 2026), ALBEMARLE CORP (Nov 2026)
Watch Vir Biotechnology, Inc.
Get an email when Vir Biotechnology, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Vir Biotechnology, Inc.?
Want the whole picture on Vir Biotechnology, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vir Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vir Biotechnology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
Tools for this story
Each opens in a new tab, filled in for Vir Biotechnology, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Vir Biotechnology, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/vir-biotechnology